WAVE LIFE SCIENCES LTD. Shareholders' Equity
WAVE LIFE SCIENCES LTD. (WVE) had Shareholders' Equity of $453.52 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-30
- 2026-06-30: Stockholders' Equity Attributable to Parent $453.52M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $511.73M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $518.36M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $124.55M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $453.52M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $511.73M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $518.36M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $124.55M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $139.27M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $171.80M 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $209.51M 10-Q · filed 2026-07-30 | |
| 2024-09-30 | $141.64M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$3.48M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $25.39M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $39.63M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$40.49M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$51.72M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | -$34.71M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | -$45.09M 10-K · filed 2026-02-26 | |
| 2022-09-30 | -$4.52M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $30.95M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | -$53.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $32.50M 10-K · filed 2025-03-04 | |
| 2021-09-30 | $29.90M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $21.84M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $52.82M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $82.78M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $108.24M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$4.49M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $20.86M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $63.73M 10-K · filed 2022-03-03 | |
| 2019-09-30 | $114.77M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $160.22M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $196.86M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $73.35M 10-K · filed 2021-03-04 | |
| 2018-09-30 | $106.61M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $139.30M 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $110.05M 10-Q · filed 2019-11-05 | |
| 2017-12-31 | $139.61M 10-K · filed 2020-03-02 | $139.81M 10-K · filed 2018-03-12 |
| 2017-09-30 | $165.86M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $188.91M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $117.09M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $134.60M 10-K · filed 2020-03-02 | $134.86M 10-K · filed 2017-03-16 |
| 2016-09-30 | $151.13M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $166.28M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $146.52M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $153.49M 10-K · filed 2019-03-01 | |
| 2015-09-30 | -$3.12M 10-Q · filed 2015-12-17 | |
| 2014-12-31 | $2.03M 10-K · filed 2018-03-12 | |
| 2013-12-31 | -$7.76M 10-K · filed 2017-03-16 | |
| 2012-12-31 | -$4.58M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |